Article Details

First Participant Dosed in Pfizer's Pivotal Phase 3 TALAPRO-3 Combination Study of Talazoparib ...

Retrieved on: 2021-06-23 11:06:46

Tags for this article:

Click the tags to see associated articles and topics

First Participant Dosed in Pfizer's Pivotal Phase 3 TALAPRO-3 Combination Study of Talazoparib .... View article details on hiswai:

Excerpt

Study explores combination in patients with DNA damage response alterations before prostate cancer becomes castration resistant Pfizer Inc. (NYSE: ...

Article found on: www.pfizer.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo